CLINICAL_TRIALS trial_result · 2012-01-20

Clinical Trial Update: Safety and Efficacy of Oral AGN 203818 for the Relief of Irritable Bowel Syndrome Pain [Phase 2]

Phase 2 trial evaluating oral AGN 203818 for relief of irritable bowel syndrome pain was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Allergan | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2012-01-20